SCMP Financial Facts

Comprehensive income (loss): 1.99M
Total revenues: 24.49M
See Full Income Statement

Accumulated other comprehensive income: -32.36M
Restricted cash: 2.47M
See Full Balance Sheet

Sucampo Pharmaceuticals (SCMP) Earnings

  |   Expand Research on SCMP
Next EPS Date 8/6/14 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate -320.8% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +13.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/7/14 Q113 $0.02$0.04 -$0.02$22.2M$24.19M N/A Details
3/13/13 Q412 $0.32$0.12 +$0.20$34.9M$32.21M N/A Details
3/13/12 Q411 $0.06N/A N/A $14.22M$15.9M N/A Details
11/3/11 Q311 -$0.10N/A N/A $14.37M$20.9M N/A Details
3/3/11 Q410 -$0.15-$0.01 -$0.14$12.4M$15.5M N/A Details